M Gold1, L A Lightfoot, T Hnath-Chisolm. 1. Department of Neurology, College of Medicine, University of South Florida, Tampa, 33612, USA.
Abstract
OBJECTIVES: To determine the prevalence and characteristics of hearing loss in patients undergoing examination because of a memory disorder, to determine whether currently used screening tools were adequate for use in this specific population, and to determine if patients with Alzheimer disease reliably report hearing problems. DESIGN: Case-control study. PATIENTS: A consecutive sample of 52 patients: 30 patients who met the National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association criteria for probable Alzheimer disease (group 1) and 22 patients with other forms of cognitive impairment (group 2). METHODS: Patients underwent a hearing screening that included a case history, a visual inspection of the external ear canal and tympanic membrane, and pure tone audiometry. Patients and their caregivers completed a questionnaire intended to assess hearing impairment and perceived disability. OUTCOME MEASURES: Pass or fail on pure tone audiometry and pass or fail on a hearing impairment questionnaire. RESULTS: Of the 52 patients, 49 had significant hearing loss. No difference was found in the failure rate between patients in groups 1 and 2. In group 1, a significant discrepancy was found between the patient's self-report and that of their caregivers, whereas in group 2, the self-report was reliable. The prevalence of hearing loss in this population greatly exceeds the prevalence in healthy aged controls. CONCLUSION: The extraordinarily high prevalence of hearing loss in this selected population suggests that a hearing evaluation should be part of any assessment of cognitive function.
OBJECTIVES: To determine the prevalence and characteristics of hearing loss in patients undergoing examination because of a memory disorder, to determine whether currently used screening tools were adequate for use in this specific population, and to determine if patients with Alzheimer disease reliably report hearing problems. DESIGN: Case-control study. PATIENTS: A consecutive sample of 52 patients: 30 patients who met the National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer's Disease and Related Disorders Association criteria for probable Alzheimer disease (group 1) and 22 patients with other forms of cognitive impairment (group 2). METHODS:Patients underwent a hearing screening that included a case history, a visual inspection of the external ear canal and tympanic membrane, and pure tone audiometry. Patients and their caregivers completed a questionnaire intended to assess hearing impairment and perceived disability. OUTCOME MEASURES: Pass or fail on pure tone audiometry and pass or fail on a hearing impairment questionnaire. RESULTS: Of the 52 patients, 49 had significant hearing loss. No difference was found in the failure rate between patients in groups 1 and 2. In group 1, a significant discrepancy was found between the patient's self-report and that of their caregivers, whereas in group 2, the self-report was reliable. The prevalence of hearing loss in this population greatly exceeds the prevalence in healthy aged controls. CONCLUSION: The extraordinarily high prevalence of hearing loss in this selected population suggests that a hearing evaluation should be part of any assessment of cognitive function.
Authors: Elizabeth M Hudak; Jennifer Bugos; Ross Andel; Jennifer J Lister; Ming Ji; Jerri D Edwards Journal: Contemp Clin Trials Date: 2019-06-18 Impact factor: 2.226
Authors: Alexander S Kim; Joshua F Betz; Marilyn Albert; Jennifer A Deal; Sarah P Faucette; Esther S Oh; Nicholas S Reed; Frank R Lin; Carrie L Nieman Journal: J Am Geriatr Soc Date: 2021-11-23 Impact factor: 7.538
Authors: Olivia Nirmalasari; Sara K Mamo; Carrie L Nieman; Allison Simpson; Jessica Zimmerman; Milap A Nowrangi; Frank R Lin; Esther S Oh Journal: Int Psychogeriatr Date: 2016-09-22 Impact factor: 3.878
Authors: Alexander S Kim; Emmanuel E Garcia Morales; Halima Amjad; Valerie T Cotter; Frank R Lin; Constantine G Lyketsos; Milap A Nowrangi; Sara K Mamo; Nicholas S Reed; Sevil Yasar; Esther S Oh; Carrie L Nieman Journal: Am J Geriatr Psychiatry Date: 2020-10-14 Impact factor: 7.996
Authors: Francesco Panza; Vincenzo Solfrizzi; Davide Seripa; Bruno P Imbimbo; Rosa Capozzo; Nicola Quaranta; Alberto Pilotto; Giancarlo Logroscino Journal: Front Aging Neurosci Date: 2015-06-09 Impact factor: 5.750
Authors: Frances Bunn; Anne-Marie Burn; Claire Goodman; Greta Rait; Sam Norton; Louise Robinson; Johan Schoeman; Carol Brayne Journal: BMC Med Date: 2014-10-31 Impact factor: 8.775
Authors: Willa D Brenowitz; Lilah M Besser; Walter A Kukull; C Dirk Keene; M Maria Glymour; Kristine Yaffe Journal: Neurology Date: 2020-08-05 Impact factor: 11.800